Further, response to carboplatin was associated with rs6010746 in the MRG domain binding protein (MRGBP), which has been identified as a potential biomarker for malignancy in pancreatic ductal adenocarcinoma [77] and reported to contribute to colorectal carcinogenesis by promoting cell proliferation in cancer cells [78]. Here, MRGBP is linked to pancreatic ductal adenocarcinoma.